iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Granules Q2 PAT rises 80% YoY; net debt to EBITDA at 0.61x

20 Oct 2022 , 02:08 PM

EBITDA improved by 61% to Rs 243 crore in Q2 FY23 from Rs 151 crore in Q2 FY22. EBITDA margin was 21% in Q2 FY23 as against 17% in Q2 FY22. The companys revenue share from the USA increased to 57.8% when compared to 53.8% YoY. Further, active pharmaceuticals ingredients (API), pharmaceutical formulation intermediates (PFI), and finished dosages contribute 29%, 20%, and 51% of revenue from operations, respectively. Free cash flow stood at Rs 124 crore for Q2 FY23 as compared to Rs 32 crore for Q2 FY22. ROCE for Q2 FY23 increased to 25% as compared to 21.8% YoY. Net debt for Q2 FY23 stood at Rs 554 crore as against Rs 613 crore in Q1 FY23. Net debt to EBITDA was at 0.61x in Q2 FY23. Dr. Krishna Prasad Chigurupati, chairman & managing director of Granules India, said, ?The current quarter result is a combination of our relentless focus for supply reliability and customer satisfaction and ability to respond and cater to higher demand with a short turnaround time. Opportunities in Paracetamol are likely to continue and our geography expansion strategy in Europe is likely to yield bigger turnover and EBITDA in future periods.? Granules India is a vertically integrated fast growing Indian pharmaceutical company. It is present across the entire manufacturing value chain – from active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), and finished dosages (FDs). The scrip fell 2.98% to currently trade at Rs 345.15 on the BSE. Powered by Capital Market – Live News

Related Tags

  • capital market
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.